In 2023, Italy's share of scientific publications among the world's top 10% most-cited in pulmonary and respiratory medicine stood below 14.65%. From 2024 onwards, forecasts indicate a steady growth, culminating at 16.45% by 2028. The average annual growth rate over these years (CAGR) is increasing, illustrating the strengthening research output and international recognition of Italy in this medical field. This positive trend underscores the country's advancing capabilities and global collaboration in medical research.

Future trends to watch for include:

Increased collaboration between Italian researchers and international institutions.
More investment in healthcare innovation and research infrastructure, potentially boosting citation impact.
Potential impacts of shifting global health priorities on publication focus and funding.